Ministry of Science & Technology

Government will collaborate with stakeholders in developing medical technology, says MoS (S&T) Dr Jitendra Singh

Indigenous technology will help reduce dependence on imports and will be in line with the vision of Prime Minister Shri Narendra Modi’s AatmaNirbhar Bharat, says Dr Jitendra Singh

Union Minister addresses the 13th CII Global MedTech Summit on the “Sunrise Medical Devices Sector in India”

Posted On: 02 SEP 2021 7:24PM by PIB Delhi

Government will collaborate with stakeholders in developing medical technology. This was stated by the Union Minister of State (Independent Charge) Science & Technology; Minister of State (Independent Charge) Earth Sciences; MoS PMO, Personnel, Public Grievances, Pensions, Atomic Energy and Space, Dr Jitendra Singh in his virtual address to the 13th CII Global MedTech Summit on the “Sunrise Medical Devices Sector in India” here today. He said, this will also help in promoting to develop indigenous technologies and will be in line with the vision of Prime Minister Shri Narendra Modi’s AatmaNirbhar Bharat.

Dr. Jitendra Singh said India’s healthcare industry has made several advances during brief 70 years since Independence and this sector is recognised as the Sunrise sector in India. “We are among the world leaders in medicare and sometimes new technologies are applied here even before these are rolled out in the West,” said Dr Jitendra Singh adding, inspite of that most medical technologies are not indigenous and we are still dependent on as much as 85% imported technologies.” “One reason being the healthcare sector has never been given priority here in India, neither social nor cultural, owing to legacy issues besides economic constraints,” he noted.

Dr.Jitendra Singh said, now all that has changed under the leadership of Prime Minister Shri Narendra Modi who promotes scientific temper, as is evident by the National Hydrogen Mission announced by PM Modi in his Independence Day address on 15th August this year. Several initiatives have been undertaken during the last seven years to promote Ease of Business and Make in India, he said. “Prime Minister has given freedom to do away with regulations that have been hampering growth of indigenous industry. Earlier, entrepreneurs were reluctant to invest as there were multiple window clearances, sometimes 70 even in small scale sector. COVID-19 has served to give a kneejerk to indigenous technologies such as CSIR in manufacturing ventilators, vaccine production by DBT, ISRO in Liquid Oxygen. Instead of Ministry/Department wise approvals, we should go for theme based projects involving the private sector. Indigenous medical technologies will help reduce dependence on imports and for this the government, private sector, corporates and scientists, all will have to come together and pool their resources. ”

India’s Medical Technology sector was worth $11 billion in 2020. A CII study estimates, this will grow up to $50 billion by 2025.

Minister of State for Commerce and Industry, Smt. Anupriya Patel, Prof. K. Vijay Raghavan, Principal Scientific Advisor to Government of India and Smt S. Aparna, Secretary, Department of Pharmaceuticals, also addressed the webinar.

***

SNC/PK/RR



(Release ID: 1751508) Visitor Counter : 678


Read this release in: Urdu , Hindi , Punjabi